Design and Synthesis of Poly(2,2'-Bipyridyl) Ligands for Induction of Cell Death in Cancer Cells: Control of Anticancer Activity by Complexation/Decomplexation with Biorelevant Metal Cations

Overview

Journal Inorg Chem

Specialty Chemistry

Date 2023 Aug 29

PMID 37642721

Authors

Chandrasekar Balachandran

Masumi Hirose

Tomohiro Tanaka

Jun Jie Zhu

Kenta Yokoi

Yosuke Hisamatsu

Yasuyuki Yamada

Shin Aoki

Affiliations

Soon will be listed here.

Abstract

Chelation therapy is a medical procedure for removing toxic metals from human organs and tissues and for the treatment of diseases by using metal-chelating agents. For example, iron chelation therapy is designed not only for the treatment of metal poisoning but also for some diseases that are induced by iron overload, cancer chemotherapy, and related diseases. However, the use of such metal chelators needs to be generally carried out very carefully, because of the side effects possibly due to the non-specific complexation with intracellular metal cations. Herein, we report on the preparation and characterization of some new poly(bpy) ligands (bpy: 2,2'-bipyridyl) that contain one-three bpy ligand moieties and their anticancer activity against Jurkat, MOLT-4, U937, HeLa S3, and A549 cell lines. The results of MTT assays revealed that the tris(bpy) and bis(bpy) ligands exhibit potent activity for inducing the cell death in cancer cells. Mechanistic studies suggest that the main pathway responsible for the cell death by these poly(bpy) ligands is apoptotic cell death. It was also found that the anticancer activity of the poly(bpy) ligands could be controlled by the complexation (anticancer activity is turned OFF) and decomplexation (anticancer activity is turned ON) with biorelevant metal cations. In this paper, these results will be described.

Citing Articles

Induction of Paraptotic Cell Death in Cancer Cells by Triptycene-Peptide Hybrids and the Revised Mechanism of Paraptosis II.

Nii M, Yamaguchi K, Tojo T, Narushima N, Aoki S Biochemistry. 2024; 63(17):2111-2130.

PMID: 39140188 PMC: 11375786. DOI: 10.1021/acs.biochem.4c00085.

Bipyraloxifene - a modified raloxifene vector against triple-negative breast cancer.

Kazimir A, Gotze T, Murganic B, Mijatovic S, Maksimovic-Ivanic D, Hey-Hawkins E RSC Med Chem. 2024; 15(6):1921-1928.

PMID: 38911151 PMC: 11187558. DOI: 10.1039/d4md00051j.

References

Yamasaki T, Terai S, Sakaida I . Deferoxamine for advanced hepatocellular carcinoma. N Engl J Med. 2011; 365(6):576-8. DOI: 10.1056/NEJMc1105726. View

Khodaverdian V, Tapadar S, Macdonald I, Xu Y, Ho P, Bridges A . Deferiprone: Pan-selective Histone Lysine Demethylase Inhibition Activity and Structure Activity Relationship Study. Sci Rep. 2019; 9(1):4802. PMC: 6423038. DOI: 10.1038/s41598-019-39214-1. View

Balachandran C, Yokoi K, Naito K, Haribabu J, Tamura Y, Umezawa M . Cyclometalated Iridium(III) Complex-Cationic Peptide Hybrids Trigger Paraptosis in Cancer Cells via an Intracellular Ca Overload from the Endoplasmic Reticulum and a Decrease in Mitochondrial Membrane Potential. Molecules. 2021; 26(22). PMC: 8623854. DOI: 10.3390/molecules26227028. View

Maclean K, Cleveland J, Porter J . Cellular zinc content is a major determinant of iron chelator-induced apoptosis of thymocytes. Blood. 2001; 98(13):3831-9. DOI: 10.1182/blood.v98.13.3831. View

Zalewski P, FORBES I, Betts W . Correlation of apoptosis with change in intracellular labile Zn(II) using zinquin [(2-methyl-8-p-toluenesulphonamido-6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II). Biochem J. 1993; 296 ( Pt 2):403-8. PMC: 1137710. DOI: 10.1042/bj2960403. View

Aoki S, Kagata D, Shiro M, Takeda K, Kimura E . Metal chelation-controlled twisted intramolecular charge transfer and its application to fluorescent sensing of metal ions and anions. J Am Chem Soc. 2004; 126(41):13377-90. DOI: 10.1021/ja040095v. View

Ninomiya T, Ohara T, Noma K, Katsura Y, Katsube R, Kashima H . Iron depletion is a novel therapeutic strategy to target cancer stem cells. Oncotarget. 2017; 8(58):98405-98416. PMC: 5716739. DOI: 10.18632/oncotarget.21846. View

Partridge B, Hartwig J . Sterically controlled iodination of arenes via iridium-catalyzed C-H borylation. Org Lett. 2012; 15(1):140-3. DOI: 10.1021/ol303164h. View

Yu Y, Gutierrez E, Kovacevic Z, Saletta F, Obeidy P, Suryo Rahmanto Y . Iron chelators for the treatment of cancer. Curr Med Chem. 2012; 19(17):2689-702. DOI: 10.2174/092986712800609706. View

10.

Yokoi K, Balachandran C, Umezawa M, Tsuchiya K, Mitric A, Aoki S . Amphiphilic Cationic Triscyclometalated Iridium(III) Complex-Peptide Hybrids Induce Paraptosis-like Cell Death of Cancer Cells via an Intracellular Ca-Dependent Pathway. ACS Omega. 2020; 5(12):6983-7001. PMC: 7114882. DOI: 10.1021/acsomega.0c00337. View

11.

Salehi S, Saljooghi A, Shiri A . Synthesis, characterization and in vitro anticancer evaluations of two novel derivatives of deferasirox iron chelator. Eur J Pharmacol. 2016; 781:209-17. DOI: 10.1016/j.ejphar.2016.04.026. View

12.

Masum A, Hisamatsu Y, Yokoi K, Aoki S . Luminescent Iridium Complex-Peptide Hybrids (IPHs) for Therapeutics of Cancer: Design and Synthesis of IPHs for Detection of Cancer Cells and Induction of Their Necrosis-Type Cell Death. Bioinorg Chem Appl. 2018; 2018:7578965. PMC: 6092981. DOI: 10.1155/2018/7578965. View

13.

Aoki S, Yokoi K, Hisamatsu Y, Balachandran C, Tamura Y, Tanaka T . Post-complexation Functionalization of Cyclometalated Iridium(III) Complexes and Applications to Biomedical and Material Sciences. Top Curr Chem (Cham). 2022; 380(5):36. DOI: 10.1007/s41061-022-00401-w. View

14.

Tian T, Song Y, Wei L, Wang J, Fu B, He Z . Reversible manipulation of the G-quadruplex structures and enzymatic reactions through supramolecular host-guest interactions. Nucleic Acids Res. 2017; 45(5):2283-2293. PMC: 5389557. DOI: 10.1093/nar/gkx025. View

15.

Sekaly A, Murimboh J, Hassan N, Mandal R, Younes M, Chakrabarti C . Kinetic speciation of Co(II), Ni(II), Cu(II), and Zn(II) in model solutions and freshwaters: lability and the d electron configuration. Environ Sci Technol. 2003; 37(1):68-74. DOI: 10.1021/es025805g. View

16.

Vervloessem T, Ivanova H, Luyten T, Parys J, Bultynck G . The selective Bcl-2 inhibitor venetoclax, a BH3 mimetic, does not dysregulate intracellular Ca signaling. Biochim Biophys Acta Mol Cell Res. 2016; 1864(6):968-976. DOI: 10.1016/j.bbamcr.2016.11.024. View

17.

Hirata H, Takahashi A, Kobayashi S, Yonehara S, Sawai H, Okazaki T . Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med. 1998; 187(4):587-600. PMC: 2212161. DOI: 10.1084/jem.187.4.587. View

18.

Matyuska F, Szorcsik A, May N, Dancs A, Kovats E, Benyei A . Tailoring the local environment around metal ions: a solution chemical and structural study of some multidentate tripodal ligands. Dalton Trans. 2017; 46(26):8626-8642. DOI: 10.1039/c7dt00104e. View

19.

Flora S, Pachauri V . Chelation in metal intoxication. Int J Environ Res Public Health. 2010; 7(7):2745-88. PMC: 2922724. DOI: 10.3390/ijerph7072745. View

20.

Pluth M, Tomat E, Lippard S . Biochemistry of mobile zinc and nitric oxide revealed by fluorescent sensors. Annu Rev Biochem. 2011; 80:333-55. PMC: 3117437. DOI: 10.1146/annurev-biochem-061009-091643. View